Open menu

Nanotechnology Spotlight

Behind the buzz and beyond the hype:
Our Nanowerk-exclusive feature articles

Nanotechnology Spotlight – Latest Articles

RSS Subscribe to our Nanotechnology Spotlight feed

Showing Spotlights 81 - 88 of 133 in category Risks, Toxicology, Biocompatibility (newest first):


Nanoparticle uptake by plants

nanoparticle_uptake_by_plantsNanoparticles with at least one dimension of 100 nanometers or less fall in the transitional zone between individual atoms or molecules and the corresponding bulk material, which can drastically modify the physicochemical properties of the material and may generate adverse biological effects in organisms. As the discussion about potentially undesired side effects of engineered nanoparticles heats up, research on toxicological effects of nanomaterials gets increasing attention. Nanotoxicology is quickly being established as a new field, with its major focus on human and animal studies. However, very few studies have been conducted to assess the toxicity of nanomaterials to ecological terrestrial species, particularly plants. So far, the mechanisms of nanoparticle phytotoxicity ? the ability to cause injury to plants ? remain largely unknown and little information on the potential uptake of nanoparticles by plants and their subsequent fate within the food chain is available.

Posted: Jul 9th, 2008

Problematic new findings regarding toxicity of silver nanoparticles

zebrafish_embryosEngineered nanoparticles are rapidly becoming a part of our daily life in the form of cosmetics, food packaging, drug delivery systems, therapeutics, biosensors, etc. A number of commercial products such as wound dressing, detergents or antimicrobial coatings are already in the market. Although little is known about their bio distribution and bio activity, especially silver nanoparticles are extensively used for all kinds of antimicrobial applications. Ultimately, these nanoparticles end up in the environment during waste disposal. Largely due to a scarcity of data on the toxicity, intracellular distribution and fate of silver ions and nanoparticles inside an organism, regulatory bodies so far have not felt the need to regulate the use of such materials in commercial products or disposal of such products. In order to improve the scientific data and to enhance our insight on the health and environmental impact of silver nanoparticles, scientists in Singapore have initiated an in vivo toxicology study to examine nanosilver in a zebrafish model. They conclude that silver nanoparticles have the potential to cause health and ecotoxicity issues in a concentration-dependent manner.

Posted: Jun 6th, 2008

German nanotechnology risk research strategy

GermanyGermany, with an almost 40% share of European public funded nanoscience research, is the clear nanotechnology leader in Europe. It is also one of the leaders globally in pushing research into potential risk and safety concerns associated with nanotechnology. The Federal Ministry of Education and Research (BMBF) is the ministry responsible for federal activities in the nanotechnology sector in Germany. Within its framework of 'leading-edge innovations' the BMBF supports key areas of nanotechnologies with promising prospects (NanoMobil, NanoChem, NanoFab, NanoforLife,NanoLux). The project NanoChance aims to support small and medium-sized companies in particular. The cooperative project NanoCare currently mainly focuses on studying possible risks of engineered nanoparticles. Beyond that, the federal agencies BAuA (Federal Institute for Occupational Safety and Health), UBA (Federal Environment Agency) and BfR (Federal Institute for Risk Assessment) have developed a joint research strategy that addresses especially health and environmental risks of engineered nanoparticles. The strategy has been finalized in December 2007 and a final report has just been published.

Posted: May 29th, 2008

Fingerprinting nanoparticles to assess cytotoxicity

cellsHigh content analysis (HCA) is a powerful platform that combines cell-based assays with traditional microscopy and automated, sophisticated image processing and analysis software. This technology is capable of using living and fixed cells, typically with fluorescently labeled antibodies and reagents. It has been widely adopted in the pharmaceutical and biotechnology industries for target identification and validation. HCA has made particular inroads into research and development applications where high throughput screening has proven inadequate, such as measuring multiple biological pathways simultaneously, or revealing off-target drug effects. HCA has stepped into this void by demonstrating how particular proteins are affected by the application of a molecule to the cell line of interest.

Posted: May 20th, 2008

The role of surfactants in carbon nanotube toxicity

lab_bottlesSynthesized carbon nanotubes, especially single-walled carbon nanotubes (SWCNTs), are in the form of bundles with other impurities such as catalyst particles and amorphous carbon debris. In order to be useful for many types of applications, for instance in nanoelectronic devices or biomedical applications, SWCNTs need to be purified and dispersed into individual nanotubes. One method to do this is by surfactant stabilization of the hydrophobic nanotube surface, which overcomes the van der Waals forces among the nanotubes and results in suspensions of individual SWCNTs. Researchers have now investigated the cytotoxicity of SWCNTs suspended in various surfactants. Their experimental results show that the conjugates SDS/CNT and SDBS/CNT are toxic to astrocytoma cells due solely to the toxicity of the SDS and SDBS molecules, which administered alone are toxic to the cells even at a low concentration of 0.05 mg per ml within 30 min. However, the proliferation and viability of the astrocytoma cells were not affected by SWCNTs and the conjugates SC/CNT and DNA/CNT.

Posted: May 19th, 2008

EU looks at the safety of nanomaterials in cosmetic products

cosmeticsThe controversy over the use of nanoparticles in everyday products, such as cosmetics, has been going on for a while now. At best, the evidence is inconclusive - it's too early to say whether there is a risk or not. The cosmetics industry of course argues that their nanoparticle-containing products are perfectly safe because no problem has been reported so far. Consumer, health and environmental groups beg to differ and claim that there is a potential risk because we just don't know enough about this issue and that we rather should err on the side of caution. The fact is, as a recent report by the European Commission's Health and Consumer Protectorate states, that at present there is inadequate information on hazard identification, exposure assessment, uptake, the role of physico-chemical parameters of nanoparticles determining absorption and transport across membranes in the gut and lungs, the role of physico-chemical parameters of nanoparticles in systemic circulation determining biokinetics and accumulation in secondary target organs, possible health effects, and translocation of nanoparticles via the placenta to the foetus. The EU report concludes that conventional risk assessment methodologies may be adequate for products that contain soluble and/or biodegradable nanoparticles but not for insoluble and/or biopersistent nanoparticles.

Posted: May 5th, 2008

Pilot toxicology study of intravenously injected carbon nanotubes

liver_histologyThe toxicity issues surrounding carbon nanotubes (CNTs) are highly relevant for two reasons: Firstly, as more and more products containing CNTs come to market, there is a chance that free CNTs get released during their life cycles, most likely during production or disposal, and find their way through the environment into the body. Secondly, and much more pertinent with regard to potential health risks, is the use of CNTs in biological and medical settings. CNTs interesting structural, chemical, electrical, and optical properties are explored by numerous research groups around the world with the goal of drastically improving performance and efficacy of biological detection, imaging, and therapy applications. In many of these envisaged applications, CNTs would be deliberately injected or implanted in the body. For instance, CNT-based intercellular molecular delivery vehicles have been developed for intracellular gene and drug delivery in vitro. What these CNTs do once inside the body and after they discharge their medical payloads is not well understood. Cell culture studies have shown evidence of cytotoxicity and oxidative stress induced by single-walled carbon nanotubes (SWCNTs), depending on whether and to what degree they are functionalized or oxidized. A new study at Stanford University tested non-covalently pegylated SWCNTs as a 'least toxic scenario', and oxidized, covalently functionalized nanotubes as a 'most toxic scenario' in a study on mice. It was found that SWCNTs injected intravenously into nude mice do not appear to have any significant toxicity during an observation period of four months following injection.

Posted: Apr 22nd, 2008

Companies fail to apprise investors of potential nanotechnology risks

investingFollowing just two days after we wrote about the food industry's deafening silence on their nanotechnology research and development, the Investor Environmental Health Network today released a report that demonstrates that sectors affected by product toxicity risks are doing a poor job of informing shareholders of market risks they face due to toxic chemicals in their products. The report specifically addresses the situation for companies dealing with nanomaterials by noting that manufacturers are not disclosing the evidence of health risks of nanotechnology products, nor the lack of adequate product testing prior to their sales. An interesting observation is that some nanomaterial manufacturers are more open to communicating potential uncertainties than their customers. These customers of the nanomaterials are the manufacturers of an array of products from electronics to food and cosmetics - and they tend not to disclose the potential health and financial risks. IEHN's conclusion is that investors should be apprised of the state of the science by a company, instead of being misled to believe that the serious questions have been answered.

Posted: Apr 18th, 2008